Display options
Cite
Rosenbloom M, Borson S, Barclay T, et al. Routine cognitive screening in a neurology practice: Effect on physician behavior. Neurol Clin Pract. 2016;6(1):16-21doi: 10.1212/CPJ.0000000000000186.
Rosenbloom, M., Borson, S., Barclay, T., Hanson, L. R., Werner, A., Stuck, L., & McCarten, J. (2016). Routine cognitive screening in a neurology practice: Effect on physician behavior. Neurology. Clinical practice, 6(1), 16-21. https://doi.org/10.1212/CPJ.0000000000000186
Rosenbloom, Michael, et al. "Routine cognitive screening in a neurology practice: Effect on physician behavior." Neurology. Clinical practice vol. 6,1 (2016): 16-21. doi: https://doi.org/10.1212/CPJ.0000000000000186
Rosenbloom M, Borson S, Barclay T, Hanson LR, Werner A, Stuck L, McCarten J. Routine cognitive screening in a neurology practice: Effect on physician behavior. Neurol Clin Pract. 2016 Feb;6(1):16-21. doi: 10.1212/CPJ.0000000000000186. PMID: 26918200; PMCID: PMC4753831.
Copy Download .nbib Format: NLM
Share it on

Neurol Clin Pract. 2016 Feb;6(1):16-21. doi: 10.1212/CPJ.0000000000000186.

Routine cognitive screening in a neurology practice: Effect on physician behavior.

Neurology. Clinical practice

Michael Rosenbloom, Soo Borson, Terry Barclay, Leah R Hanson, Ann Werner, Logan Stuck, John McCarten

Affiliations

  1. HealthPartners Center for Memory and Aging (MR, TB, LRH), St. Paul; Department of Neurology (MR, JM), University of Minnesota Medical School, Minneapolis; Geriatric Research, Education and Clinical Center (GRECC) (JM), Minneapolis VA Health Care System, MN; the University of Washington School of Nursing (SB), University of Washington School of Medicine, Seattle; and HealthPartners Institute for Research and Education (LRH, AW, LS), Bloomington, MN.

PMID: 26918200 PMCID: PMC4753831 DOI: 10.1212/CPJ.0000000000000186

Abstract

BACKGROUND: Alzheimer disease is one of the most prevalent and costly neurologic disorders. American Academy of Neurology guidelines call for diagnosis and treatment when dementia is present, but provide no specific instruction relating to cognitive screening.

METHODS: Our center piloted a cognitive screening initiative using the Mini-Cog, which was administered to all neurology patients aged ≥70 years without a history of a cognitive disorder.

RESULTS: There was a 37.4% screen positive rate on the Mini-Cog. The percentage of patients with subjective memory complaints did not differ between patients screening positive vs negative on the Mini-Cog. Prospective analysis over an 18-month postscreening period showed that individuals screening positive for cognitive impairment were 10 times more likely to have follow-up cognitive assessment by the provider (

CONCLUSION: Further studies are needed to better understand factors influencing neurologist actions in the evaluation and treatment of cognitive impairment.

References

  1. Int Psychogeriatr. 2010 May;22(3):346-72 - PubMed
  2. Neurology. 2001 May 8;56(9):1143-53 - PubMed
  3. Ann Intern Med. 2013 Nov 5;159(9):601-12 - PubMed
  4. J Gen Intern Med. 2007 Jun;22(6):811-7 - PubMed
  5. J Am Geriatr Soc. 2011 Feb;59(2):309-13 - PubMed
  6. Alzheimers Dement. 2009 May;5(3):215-26 - PubMed
  7. JAMA Intern Med. 2015 Sep;175(9):1450-8 - PubMed
  8. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005593 - PubMed
  9. Int J Geriatr Psychiatry. 2000 Nov;15(11):1021-7 - PubMed
  10. J Am Geriatr Soc. 2003 Oct;51(10):1451-4 - PubMed
  11. Neurology. 2015 Jan 6;84(1):64-71 - PubMed
  12. N Engl J Med. 2013 Aug 1;369(5):489-90 - PubMed

Publication Types

Grant support